These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 18270211

  • 1. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y, Ohmori T, Hoshide S, Madoiwa S, Yamamoto K, Katsuki T, Mitsuhashi T, Mimuro J, Shimada K, Kario K, Sakata Y.
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [Abstract] [Full Text] [Related]

  • 2. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG.
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [Abstract] [Full Text] [Related]

  • 3. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW, Topcu Y, Postma S, Kelder JC, Hackeng CM, ten Berg JM, Verheugt FW.
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract] [Full Text] [Related]

  • 6. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT, Regal RE, Dorsch MP.
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [Abstract] [Full Text] [Related]

  • 7. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW.
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, Abbate R, Gori AM.
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [Abstract] [Full Text] [Related]

  • 9. Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention.
    Obradovic SD, Antovic JP, Antonijevic NM, Ratkovic NG, Vojvodic DV, Subota VS, Gligic BLj, Obradovic DV, Marinkovic JM, Wallen HN.
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):283-9. PubMed ID: 19318922
    [Abstract] [Full Text] [Related]

  • 10. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease.
    Cheng G, Shan J, Xu G, Liu P, Zhou Y, Zhu Y, Lu X.
    J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):1-14. PubMed ID: 19089929
    [Abstract] [Full Text] [Related]

  • 13. Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease.
    Peace AJ, Tedesco AF, Foley DP, Dicker P, Berndt MC, Kenny D.
    J Thromb Haemost; 2008 Dec 01; 6(12):2027-34. PubMed ID: 18823340
    [Abstract] [Full Text] [Related]

  • 14. The influence of bisoprolol dose on ADP-induced platelet aggregability in patients on dual antiplatelet therapy.
    Ignjatovic VS, Petrovic N, Miloradovic V, Ignjatovic S, Cokanovic V, Grdinic A, Simic I, Petrovic I, Nikolic S, Andjelkovic A, Paramentic D, Ignjatovic S.
    Coron Artery Dis; 2010 Dec 01; 21(8):472-6. PubMed ID: 20861734
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun 01; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.
    Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 15; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 18. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A, Stepień E, Branicka A, Wołkow P, Zmudka K, Tracz W.
    Kardiol Pol; 2009 Jun 15; 67(6):591-8. PubMed ID: 19618315
    [Abstract] [Full Text] [Related]

  • 19. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
    Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G.
    J Am Coll Cardiol; 2008 Sep 30; 52(14):1128-33. PubMed ID: 18804738
    [Abstract] [Full Text] [Related]

  • 20. Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection.
    Modica A, Karlsson F, Mooe T.
    J Thromb Haemost; 2007 Mar 30; 5(3):507-11. PubMed ID: 17319905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.